Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 31802120.
- Also identified by DOI 10.1093/infdis/jiz645.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The World Health Organization recommends intradermal (ID) administration of rabies vaccine for preexposure prophylaxis. In a randomized trial in adults assigned to 1 of 6 treatment groups (ID vs intramuscular [IM], 2 vs 3 doses, and controls), rabies neutralizing antibody titers were measured to 1 year postvaccination. ID vaccination produced acceptable antibody levels in all subjects (2- and 3-dose groups). At day 365, acceptable levels were 40% for IM and 50% for ID 2-dose schedule, and 70% for IM and 60% for ID 3-dose schedule. ID rabies vaccination induces acceptable antibody titers at a fraction of the dose. NCT02374814.
Medical subject headings
- Antibodies, Neutralizing
- Immunogenicity, Vaccine
- Rabies
- Rabies Vaccines